Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02758353Completed
Open-label trial of sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by JSI Research & Training Institute. Primary endpoint: Percentage of participants that got SP coverage among all pregnant women up to 7 months. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02758353.